nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—Pancreatitis—Sorafenib—liver cancer	0.00511	0.0078	CcSEcCtD
Oxaprozin—Pneumonia—Sorafenib—liver cancer	0.00467	0.00713	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.0046	0.00703	CcSEcCtD
Oxaprozin—Acute coronary syndrome—Sorafenib—liver cancer	0.00458	0.00699	CcSEcCtD
Oxaprozin—Renal failure—Sorafenib—liver cancer	0.00456	0.00697	CcSEcCtD
Oxaprozin—Myocardial infarction—Sorafenib—liver cancer	0.00455	0.00695	CcSEcCtD
Oxaprozin—Jaundice—Sorafenib—liver cancer	0.00453	0.00691	CcSEcCtD
Oxaprozin—Stomatitis—Sorafenib—liver cancer	0.00453	0.00691	CcSEcCtD
Oxaprozin—Haematemesis—Epirubicin—liver cancer	0.00442	0.00674	CcSEcCtD
Oxaprozin—Haemoglobin—Sorafenib—liver cancer	0.00419	0.0064	CcSEcCtD
Oxaprozin—Haemorrhage—Sorafenib—liver cancer	0.00417	0.00637	CcSEcCtD
Oxaprozin—Haematemesis—Doxorubicin—liver cancer	0.00409	0.00624	CcSEcCtD
Oxaprozin—Erythema multiforme—Sorafenib—liver cancer	0.00394	0.00602	CcSEcCtD
Oxaprozin—Tinnitus—Sorafenib—liver cancer	0.00389	0.00593	CcSEcCtD
Oxaprozin—Arrhythmia—Sorafenib—liver cancer	0.00372	0.00569	CcSEcCtD
Oxaprozin—Alopecia—Sorafenib—liver cancer	0.00368	0.00562	CcSEcCtD
Oxaprozin—Dysgeusia—Sorafenib—liver cancer	0.00355	0.00543	CcSEcCtD
Oxaprozin—Rectal haemorrhage—Epirubicin—liver cancer	0.0034	0.00519	CcSEcCtD
Oxaprozin—Anaemia—Sorafenib—liver cancer	0.00335	0.00512	CcSEcCtD
Oxaprozin—Oliguria—Epirubicin—liver cancer	0.00333	0.00508	CcSEcCtD
Oxaprozin—Glossitis—Epirubicin—liver cancer	0.00333	0.00508	CcSEcCtD
Oxaprozin—Angioedema—Sorafenib—liver cancer	0.00332	0.00506	CcSEcCtD
Oxaprozin—Syncope—Sorafenib—liver cancer	0.00325	0.00497	CcSEcCtD
Oxaprozin—Leukopenia—Sorafenib—liver cancer	0.00325	0.00496	CcSEcCtD
Oxaprozin—Ulcer—Epirubicin—liver cancer	0.00324	0.00495	CcSEcCtD
Oxaprozin—Loss of consciousness—Sorafenib—liver cancer	0.00319	0.00487	CcSEcCtD
Oxaprozin—Rectal haemorrhage—Doxorubicin—liver cancer	0.00314	0.0048	CcSEcCtD
Oxaprozin—Hypertension—Sorafenib—liver cancer	0.00313	0.00478	CcSEcCtD
Oxaprozin—Glossitis—Doxorubicin—liver cancer	0.00308	0.0047	CcSEcCtD
Oxaprozin—Oliguria—Doxorubicin—liver cancer	0.00308	0.0047	CcSEcCtD
Oxaprozin—Dry mouth—Sorafenib—liver cancer	0.00302	0.00461	CcSEcCtD
Oxaprozin—Eructation—Epirubicin—liver cancer	0.00301	0.0046	CcSEcCtD
Oxaprozin—Ulcer—Doxorubicin—liver cancer	0.003	0.00458	CcSEcCtD
Oxaprozin—Melaena—Epirubicin—liver cancer	0.003	0.00458	CcSEcCtD
Oxaprozin—Cystitis noninfective—Epirubicin—liver cancer	0.003	0.00458	CcSEcCtD
Oxaprozin—Cystitis—Epirubicin—liver cancer	0.00296	0.00452	CcSEcCtD
Oxaprozin—Anaphylactic shock—Sorafenib—liver cancer	0.00296	0.00452	CcSEcCtD
Oxaprozin—Infection—Sorafenib—liver cancer	0.00294	0.00449	CcSEcCtD
Oxaprozin—Shock—Sorafenib—liver cancer	0.00291	0.00445	CcSEcCtD
Oxaprozin—Thrombocytopenia—Sorafenib—liver cancer	0.0029	0.00443	CcSEcCtD
Oxaprozin—Aplastic anaemia—Epirubicin—liver cancer	0.00288	0.0044	CcSEcCtD
Oxaprozin—Anorexia—Sorafenib—liver cancer	0.00282	0.00431	CcSEcCtD
Oxaprozin—Oesophagitis—Epirubicin—liver cancer	0.0028	0.00428	CcSEcCtD
Oxaprozin—Coma—Epirubicin—liver cancer	0.0028	0.00428	CcSEcCtD
Oxaprozin—Eructation—Doxorubicin—liver cancer	0.00279	0.00426	CcSEcCtD
Oxaprozin—Ecchymosis—Epirubicin—liver cancer	0.00277	0.00424	CcSEcCtD
Oxaprozin—Bladder pain—Epirubicin—liver cancer	0.00277	0.00424	CcSEcCtD
Oxaprozin—Cystitis noninfective—Doxorubicin—liver cancer	0.00277	0.00423	CcSEcCtD
Oxaprozin—Melaena—Doxorubicin—liver cancer	0.00277	0.00423	CcSEcCtD
Oxaprozin—Cystitis—Doxorubicin—liver cancer	0.00274	0.00419	CcSEcCtD
Oxaprozin—Aplastic anaemia—Doxorubicin—liver cancer	0.00266	0.00407	CcSEcCtD
Oxaprozin—Sepsis—Epirubicin—liver cancer	0.00266	0.00407	CcSEcCtD
Oxaprozin—Dyspnoea—Sorafenib—liver cancer	0.00264	0.00403	CcSEcCtD
Oxaprozin—Lymphadenopathy—Epirubicin—liver cancer	0.00261	0.00399	CcSEcCtD
Oxaprozin—Dyspepsia—Sorafenib—liver cancer	0.00261	0.00398	CcSEcCtD
Oxaprozin—Coma—Doxorubicin—liver cancer	0.00259	0.00396	CcSEcCtD
Oxaprozin—Oesophagitis—Doxorubicin—liver cancer	0.00259	0.00396	CcSEcCtD
Oxaprozin—Decreased appetite—Sorafenib—liver cancer	0.00257	0.00393	CcSEcCtD
Oxaprozin—Ecchymosis—Doxorubicin—liver cancer	0.00257	0.00392	CcSEcCtD
Oxaprozin—Bladder pain—Doxorubicin—liver cancer	0.00257	0.00392	CcSEcCtD
Oxaprozin—Photosensitivity—Epirubicin—liver cancer	0.00254	0.00387	CcSEcCtD
Oxaprozin—Constipation—Sorafenib—liver cancer	0.00253	0.00387	CcSEcCtD
Oxaprozin—Vascular purpura—Epirubicin—liver cancer	0.00249	0.0038	CcSEcCtD
Oxaprozin—Hepatic failure—Epirubicin—liver cancer	0.00248	0.00378	CcSEcCtD
Oxaprozin—Sepsis—Doxorubicin—liver cancer	0.00246	0.00376	CcSEcCtD
Oxaprozin—Cardiac failure congestive—Epirubicin—liver cancer	0.00246	0.00375	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Sorafenib—liver cancer	0.00242	0.0037	CcSEcCtD
Oxaprozin—Lymphadenopathy—Doxorubicin—liver cancer	0.00241	0.00369	CcSEcCtD
Oxaprozin—Renal failure acute—Epirubicin—liver cancer	0.00241	0.00368	CcSEcCtD
Oxaprozin—Dermatitis exfoliative—Epirubicin—liver cancer	0.00236	0.0036	CcSEcCtD
Oxaprozin—Urticaria—Sorafenib—liver cancer	0.00235	0.00359	CcSEcCtD
Oxaprozin—Photosensitivity—Doxorubicin—liver cancer	0.00235	0.00358	CcSEcCtD
Oxaprozin—Abdominal pain—Sorafenib—liver cancer	0.00234	0.00357	CcSEcCtD
Oxaprozin—Body temperature increased—Sorafenib—liver cancer	0.00234	0.00357	CcSEcCtD
Oxaprozin—Renal impairment—Epirubicin—liver cancer	0.00234	0.00357	CcSEcCtD
Oxaprozin—Purpura—Epirubicin—liver cancer	0.00231	0.00353	CcSEcCtD
Oxaprozin—Vascular purpura—Doxorubicin—liver cancer	0.0023	0.00352	CcSEcCtD
Oxaprozin—Anaphylactoid reaction—Epirubicin—liver cancer	0.0023	0.00351	CcSEcCtD
Oxaprozin—Hepatic failure—Doxorubicin—liver cancer	0.00229	0.0035	CcSEcCtD
Oxaprozin—Lethargy—Epirubicin—liver cancer	0.00227	0.00347	CcSEcCtD
Oxaprozin—Cardiac failure congestive—Doxorubicin—liver cancer	0.00227	0.00347	CcSEcCtD
Oxaprozin—Renal failure acute—Doxorubicin—liver cancer	0.00223	0.00341	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00223	0.0034	CcSEcCtD
Oxaprozin—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00218	0.00333	CcSEcCtD
Oxaprozin—Renal impairment—Doxorubicin—liver cancer	0.00216	0.00331	CcSEcCtD
Oxaprozin—Purpura—Doxorubicin—liver cancer	0.00214	0.00326	CcSEcCtD
Oxaprozin—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00213	0.00325	CcSEcCtD
Oxaprozin—Asthenia—Sorafenib—liver cancer	0.00212	0.00324	CcSEcCtD
Oxaprozin—Lethargy—Doxorubicin—liver cancer	0.0021	0.00321	CcSEcCtD
Oxaprozin—Pruritus—Sorafenib—liver cancer	0.0021	0.0032	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00206	0.00315	CcSEcCtD
Oxaprozin—Abdominal pain upper—Epirubicin—liver cancer	0.00203	0.00311	CcSEcCtD
Oxaprozin—Diarrhoea—Sorafenib—liver cancer	0.00203	0.00309	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00201	0.00306	CcSEcCtD
Oxaprozin—Bifonazole—CYP2E1—liver cancer	0.00197	0.292	CrCbGaD
Oxaprozin—Gastritis—Epirubicin—liver cancer	0.00197	0.00301	CcSEcCtD
Oxaprozin—Dizziness—Sorafenib—liver cancer	0.00196	0.00299	CcSEcCtD
Oxaprozin—Asthma—Epirubicin—liver cancer	0.00192	0.00294	CcSEcCtD
Oxaprozin—Eosinophilia—Epirubicin—liver cancer	0.00191	0.00291	CcSEcCtD
Oxaprozin—Pancreatitis—Epirubicin—liver cancer	0.00189	0.00288	CcSEcCtD
Oxaprozin—Vomiting—Sorafenib—liver cancer	0.00188	0.00288	CcSEcCtD
Oxaprozin—Abdominal pain upper—Doxorubicin—liver cancer	0.00188	0.00287	CcSEcCtD
Oxaprozin—Rash—Sorafenib—liver cancer	0.00187	0.00285	CcSEcCtD
Oxaprozin—Dermatitis—Sorafenib—liver cancer	0.00187	0.00285	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00186	0.00283	CcSEcCtD
Oxaprozin—Headache—Sorafenib—liver cancer	0.00186	0.00283	CcSEcCtD
Oxaprozin—Pancytopenia—Epirubicin—liver cancer	0.00183	0.00279	CcSEcCtD
Oxaprozin—Gastritis—Doxorubicin—liver cancer	0.00182	0.00278	CcSEcCtD
Oxaprozin—Dysuria—Epirubicin—liver cancer	0.0018	0.00275	CcSEcCtD
Oxaprozin—Asthma—Doxorubicin—liver cancer	0.00178	0.00272	CcSEcCtD
Oxaprozin—Eosinophilia—Doxorubicin—liver cancer	0.00176	0.00269	CcSEcCtD
Oxaprozin—Nausea—Sorafenib—liver cancer	0.00176	0.00269	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Epirubicin—liver cancer	0.00176	0.00268	CcSEcCtD
Oxaprozin—Pancreatitis—Doxorubicin—liver cancer	0.00175	0.00267	CcSEcCtD
Oxaprozin—Hyperglycaemia—Epirubicin—liver cancer	0.00174	0.00265	CcSEcCtD
Oxaprozin—Pneumonia—Epirubicin—liver cancer	0.00173	0.00264	CcSEcCtD
Oxaprozin—Drowsiness—Epirubicin—liver cancer	0.00172	0.00262	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.0017	0.0026	CcSEcCtD
Oxaprozin—Pancytopenia—Doxorubicin—liver cancer	0.00169	0.00258	CcSEcCtD
Oxaprozin—Renal failure—Epirubicin—liver cancer	0.00169	0.00258	CcSEcCtD
Oxaprozin—Stomatitis—Epirubicin—liver cancer	0.00167	0.00255	CcSEcCtD
Oxaprozin—Jaundice—Epirubicin—liver cancer	0.00167	0.00255	CcSEcCtD
Oxaprozin—Conjunctivitis—Epirubicin—liver cancer	0.00167	0.00255	CcSEcCtD
Oxaprozin—Dysuria—Doxorubicin—liver cancer	0.00167	0.00254	CcSEcCtD
Oxaprozin—Haematuria—Epirubicin—liver cancer	0.00164	0.0025	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Doxorubicin—liver cancer	0.00163	0.00248	CcSEcCtD
Oxaprozin—Sinusitis—Epirubicin—liver cancer	0.00161	0.00246	CcSEcCtD
Oxaprozin—Hyperglycaemia—Doxorubicin—liver cancer	0.00161	0.00245	CcSEcCtD
Oxaprozin—Agranulocytosis—Epirubicin—liver cancer	0.0016	0.00245	CcSEcCtD
Oxaprozin—Pneumonia—Doxorubicin—liver cancer	0.0016	0.00244	CcSEcCtD
Oxaprozin—Drowsiness—Doxorubicin—liver cancer	0.00159	0.00242	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00157	0.0024	CcSEcCtD
Oxaprozin—Renal failure—Doxorubicin—liver cancer	0.00156	0.00238	CcSEcCtD
Oxaprozin—Warfarin—CYP1A1—liver cancer	0.00156	0.231	CrCbGaD
Oxaprozin—Haemoglobin—Epirubicin—liver cancer	0.00155	0.00236	CcSEcCtD
Oxaprozin—Stomatitis—Doxorubicin—liver cancer	0.00155	0.00236	CcSEcCtD
Oxaprozin—Jaundice—Doxorubicin—liver cancer	0.00155	0.00236	CcSEcCtD
Oxaprozin—Conjunctivitis—Doxorubicin—liver cancer	0.00154	0.00236	CcSEcCtD
Oxaprozin—Hepatitis—Epirubicin—liver cancer	0.00154	0.00235	CcSEcCtD
Oxaprozin—Haemorrhage—Epirubicin—liver cancer	0.00154	0.00235	CcSEcCtD
Oxaprozin—Haematuria—Doxorubicin—liver cancer	0.00151	0.00231	CcSEcCtD
Oxaprozin—Sinusitis—Doxorubicin—liver cancer	0.00149	0.00227	CcSEcCtD
Oxaprozin—Agranulocytosis—Doxorubicin—liver cancer	0.00148	0.00226	CcSEcCtD
Oxaprozin—Erythema multiforme—Epirubicin—liver cancer	0.00146	0.00222	CcSEcCtD
Oxaprozin—Tinnitus—Epirubicin—liver cancer	0.00144	0.00219	CcSEcCtD
Oxaprozin—Haemoglobin—Doxorubicin—liver cancer	0.00143	0.00219	CcSEcCtD
Oxaprozin—Haemorrhage—Doxorubicin—liver cancer	0.00143	0.00218	CcSEcCtD
Oxaprozin—Hepatitis—Doxorubicin—liver cancer	0.00143	0.00218	CcSEcCtD
Oxaprozin—Arrhythmia—Epirubicin—liver cancer	0.00138	0.0021	CcSEcCtD
Oxaprozin—Alopecia—Epirubicin—liver cancer	0.00136	0.00208	CcSEcCtD
Oxaprozin—Erythema multiforme—Doxorubicin—liver cancer	0.00135	0.00206	CcSEcCtD
Oxaprozin—Tinnitus—Doxorubicin—liver cancer	0.00133	0.00203	CcSEcCtD
Oxaprozin—Flatulence—Epirubicin—liver cancer	0.00132	0.00202	CcSEcCtD
Oxaprozin—Tension—Epirubicin—liver cancer	0.00132	0.00201	CcSEcCtD
Oxaprozin—Dysgeusia—Epirubicin—liver cancer	0.00131	0.00201	CcSEcCtD
Oxaprozin—Nervousness—Epirubicin—liver cancer	0.0013	0.00199	CcSEcCtD
Oxaprozin—Arrhythmia—Doxorubicin—liver cancer	0.00127	0.00194	CcSEcCtD
Oxaprozin—Vision blurred—Epirubicin—liver cancer	0.00126	0.00193	CcSEcCtD
Oxaprozin—Alopecia—Doxorubicin—liver cancer	0.00126	0.00192	CcSEcCtD
Oxaprozin—Ill-defined disorder—Epirubicin—liver cancer	0.00124	0.0019	CcSEcCtD
Oxaprozin—Anaemia—Epirubicin—liver cancer	0.00124	0.00189	CcSEcCtD
Oxaprozin—Flatulence—Doxorubicin—liver cancer	0.00122	0.00187	CcSEcCtD
Oxaprozin—Tension—Doxorubicin—liver cancer	0.00122	0.00186	CcSEcCtD
Oxaprozin—Dysgeusia—Doxorubicin—liver cancer	0.00122	0.00186	CcSEcCtD
Oxaprozin—Malaise—Epirubicin—liver cancer	0.00121	0.00185	CcSEcCtD
Oxaprozin—Nervousness—Doxorubicin—liver cancer	0.00121	0.00184	CcSEcCtD
Oxaprozin—Vertigo—Epirubicin—liver cancer	0.0012	0.00184	CcSEcCtD
Oxaprozin—Syncope—Epirubicin—liver cancer	0.0012	0.00184	CcSEcCtD
Oxaprozin—Leukopenia—Epirubicin—liver cancer	0.0012	0.00183	CcSEcCtD
Oxaprozin—Palpitations—Epirubicin—liver cancer	0.00119	0.00181	CcSEcCtD
Oxaprozin—Loss of consciousness—Epirubicin—liver cancer	0.00118	0.0018	CcSEcCtD
Oxaprozin—Vision blurred—Doxorubicin—liver cancer	0.00117	0.00179	CcSEcCtD
Oxaprozin—Convulsion—Epirubicin—liver cancer	0.00116	0.00177	CcSEcCtD
Oxaprozin—Hypertension—Epirubicin—liver cancer	0.00116	0.00177	CcSEcCtD
Oxaprozin—Ill-defined disorder—Doxorubicin—liver cancer	0.00115	0.00176	CcSEcCtD
Oxaprozin—Anaemia—Doxorubicin—liver cancer	0.00115	0.00175	CcSEcCtD
Oxaprozin—Anxiety—Epirubicin—liver cancer	0.00114	0.00174	CcSEcCtD
Oxaprozin—Discomfort—Epirubicin—liver cancer	0.00113	0.00172	CcSEcCtD
Oxaprozin—Malaise—Doxorubicin—liver cancer	0.00112	0.00171	CcSEcCtD
Oxaprozin—Dry mouth—Epirubicin—liver cancer	0.00112	0.00171	CcSEcCtD
Oxaprozin—Vertigo—Doxorubicin—liver cancer	0.00111	0.0017	CcSEcCtD
Oxaprozin—Syncope—Doxorubicin—liver cancer	0.00111	0.0017	CcSEcCtD
Oxaprozin—Leukopenia—Doxorubicin—liver cancer	0.00111	0.0017	CcSEcCtD
Oxaprozin—Confusional state—Epirubicin—liver cancer	0.0011	0.00169	CcSEcCtD
Oxaprozin—Palpitations—Doxorubicin—liver cancer	0.0011	0.00167	CcSEcCtD
Oxaprozin—Anaphylactic shock—Epirubicin—liver cancer	0.00109	0.00167	CcSEcCtD
Oxaprozin—Oedema—Epirubicin—liver cancer	0.00109	0.00167	CcSEcCtD
Oxaprozin—Loss of consciousness—Doxorubicin—liver cancer	0.00109	0.00167	CcSEcCtD
Oxaprozin—Infection—Epirubicin—liver cancer	0.00109	0.00166	CcSEcCtD
Oxaprozin—Shock—Epirubicin—liver cancer	0.00108	0.00164	CcSEcCtD
Oxaprozin—Convulsion—Doxorubicin—liver cancer	0.00108	0.00164	CcSEcCtD
Oxaprozin—Thrombocytopenia—Epirubicin—liver cancer	0.00107	0.00164	CcSEcCtD
Oxaprozin—Hypertension—Doxorubicin—liver cancer	0.00107	0.00164	CcSEcCtD
Oxaprozin—Tachycardia—Epirubicin—liver cancer	0.00107	0.00163	CcSEcCtD
Oxaprozin—Hyperhidrosis—Epirubicin—liver cancer	0.00106	0.00162	CcSEcCtD
Oxaprozin—Anxiety—Doxorubicin—liver cancer	0.00105	0.00161	CcSEcCtD
Oxaprozin—Discomfort—Doxorubicin—liver cancer	0.00104	0.00159	CcSEcCtD
Oxaprozin—Anorexia—Epirubicin—liver cancer	0.00104	0.00159	CcSEcCtD
Oxaprozin—Dry mouth—Doxorubicin—liver cancer	0.00103	0.00158	CcSEcCtD
Oxaprozin—Hypotension—Epirubicin—liver cancer	0.00102	0.00156	CcSEcCtD
Oxaprozin—Confusional state—Doxorubicin—liver cancer	0.00102	0.00156	CcSEcCtD
Oxaprozin—Oedema—Doxorubicin—liver cancer	0.00101	0.00155	CcSEcCtD
Oxaprozin—Anaphylactic shock—Doxorubicin—liver cancer	0.00101	0.00155	CcSEcCtD
Oxaprozin—Infection—Doxorubicin—liver cancer	0.00101	0.00154	CcSEcCtD
Oxaprozin—Shock—Doxorubicin—liver cancer	0.000996	0.00152	CcSEcCtD
Oxaprozin—Thrombocytopenia—Doxorubicin—liver cancer	0.000992	0.00151	CcSEcCtD
Oxaprozin—Insomnia—Epirubicin—liver cancer	0.00099	0.00151	CcSEcCtD
Oxaprozin—Tachycardia—Doxorubicin—liver cancer	0.000988	0.00151	CcSEcCtD
Oxaprozin—Paraesthesia—Epirubicin—liver cancer	0.000983	0.0015	CcSEcCtD
Oxaprozin—Phenprocoumon—ALB—liver cancer	0.000979	0.145	CrCbGaD
Oxaprozin—Hyperhidrosis—Doxorubicin—liver cancer	0.000979	0.00149	CcSEcCtD
Oxaprozin—Dyspnoea—Epirubicin—liver cancer	0.000976	0.00149	CcSEcCtD
Oxaprozin—Somnolence—Epirubicin—liver cancer	0.000973	0.00149	CcSEcCtD
Oxaprozin—Anorexia—Doxorubicin—liver cancer	0.000965	0.00147	CcSEcCtD
Oxaprozin—Dyspepsia—Epirubicin—liver cancer	0.000963	0.00147	CcSEcCtD
Oxaprozin—Decreased appetite—Epirubicin—liver cancer	0.000951	0.00145	CcSEcCtD
Oxaprozin—Hypotension—Doxorubicin—liver cancer	0.000946	0.00145	CcSEcCtD
Oxaprozin—Constipation—Epirubicin—liver cancer	0.000936	0.00143	CcSEcCtD
Oxaprozin—Insomnia—Doxorubicin—liver cancer	0.000916	0.0014	CcSEcCtD
Oxaprozin—Paraesthesia—Doxorubicin—liver cancer	0.000909	0.00139	CcSEcCtD
Oxaprozin—Dyspnoea—Doxorubicin—liver cancer	0.000903	0.00138	CcSEcCtD
Oxaprozin—Feeling abnormal—Epirubicin—liver cancer	0.000902	0.00138	CcSEcCtD
Oxaprozin—Somnolence—Doxorubicin—liver cancer	0.0009	0.00137	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Epirubicin—liver cancer	0.000895	0.00137	CcSEcCtD
Oxaprozin—Dyspepsia—Doxorubicin—liver cancer	0.000891	0.00136	CcSEcCtD
Oxaprozin—Decreased appetite—Doxorubicin—liver cancer	0.00088	0.00134	CcSEcCtD
Oxaprozin—Urticaria—Epirubicin—liver cancer	0.000869	0.00133	CcSEcCtD
Oxaprozin—Warfarin—ALB—liver cancer	0.000869	0.129	CrCbGaD
Oxaprozin—Constipation—Doxorubicin—liver cancer	0.000866	0.00132	CcSEcCtD
Oxaprozin—Body temperature increased—Epirubicin—liver cancer	0.000865	0.00132	CcSEcCtD
Oxaprozin—Abdominal pain—Epirubicin—liver cancer	0.000865	0.00132	CcSEcCtD
Oxaprozin—Feeling abnormal—Doxorubicin—liver cancer	0.000834	0.00127	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000828	0.00126	CcSEcCtD
Oxaprozin—CYP2C9—Metapathway biotransformation—GSTA4—liver cancer	0.000807	0.00238	CbGpPWpGaD
Oxaprozin—Urticaria—Doxorubicin—liver cancer	0.000804	0.00123	CcSEcCtD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000803	0.00237	CbGpPWpGaD
Oxaprozin—Abdominal pain—Doxorubicin—liver cancer	0.000801	0.00122	CcSEcCtD
Oxaprozin—Body temperature increased—Doxorubicin—liver cancer	0.000801	0.00122	CcSEcCtD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—liver cancer	0.000798	0.00236	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GSTA2—liver cancer	0.000797	0.00236	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—liver cancer	0.000796	0.00235	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—SERPINE1—liver cancer	0.000789	0.00233	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—ALB—liver cancer	0.000787	0.00233	CbGpPWpGaD
Oxaprozin—Asthenia—Epirubicin—liver cancer	0.000785	0.0012	CcSEcCtD
Oxaprozin—PTGS1—Biological oxidations—GSTP1—liver cancer	0.000778	0.0023	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—liver cancer	0.000775	0.00229	CbGpPWpGaD
Oxaprozin—Pruritus—Epirubicin—liver cancer	0.000774	0.00118	CcSEcCtD
Oxaprozin—CYP2C9—Biological oxidations—GSTA1—liver cancer	0.000769	0.00227	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—NAT2—liver cancer	0.000761	0.00225	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—F2—liver cancer	0.000752	0.00222	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—NAT2—liver cancer	0.00075	0.00222	CbGpPWpGaD
Oxaprozin—Diarrhoea—Epirubicin—liver cancer	0.000749	0.00114	CcSEcCtD
Oxaprozin—PTGS2—Disease—APCS—liver cancer	0.000745	0.0022	CbGpPWpGaD
Oxaprozin—Flurbiprofen—ALB—liver cancer	0.000741	0.11	CrCbGaD
Oxaprozin—Asthenia—Doxorubicin—liver cancer	0.000727	0.00111	CcSEcCtD
Oxaprozin—Dizziness—Epirubicin—liver cancer	0.000724	0.00111	CcSEcCtD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000724	0.00214	CbGpPWpGaD
Oxaprozin—Pruritus—Doxorubicin—liver cancer	0.000716	0.00109	CcSEcCtD
Oxaprozin—PTGS1—Biological oxidations—GSTM1—liver cancer	0.000715	0.00211	CbGpPWpGaD
Oxaprozin—Vomiting—Epirubicin—liver cancer	0.000696	0.00106	CcSEcCtD
Oxaprozin—Diarrhoea—Doxorubicin—liver cancer	0.000693	0.00106	CcSEcCtD
Oxaprozin—Rash—Epirubicin—liver cancer	0.00069	0.00105	CcSEcCtD
Oxaprozin—Dermatitis—Epirubicin—liver cancer	0.000689	0.00105	CcSEcCtD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000689	0.00204	CbGpPWpGaD
Oxaprozin—Headache—Epirubicin—liver cancer	0.000686	0.00105	CcSEcCtD
Oxaprozin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—liver cancer	0.00068	0.00201	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP1A1—liver cancer	0.000677	0.002	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00067	0.00198	CbGpPWpGaD
Oxaprozin—Dizziness—Doxorubicin—liver cancer	0.00067	0.00102	CcSEcCtD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000666	0.00197	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000665	0.00196	CbGpPWpGaD
Oxaprozin—Nausea—Epirubicin—liver cancer	0.00065	0.000993	CcSEcCtD
Oxaprozin—Vomiting—Doxorubicin—liver cancer	0.000644	0.000983	CcSEcCtD
Oxaprozin—Rash—Doxorubicin—liver cancer	0.000639	0.000975	CcSEcCtD
Oxaprozin—Dermatitis—Doxorubicin—liver cancer	0.000638	0.000974	CcSEcCtD
Oxaprozin—CYP2C9—Metapathway biotransformation—GPX3—liver cancer	0.000638	0.00188	CbGpPWpGaD
Oxaprozin—Headache—Doxorubicin—liver cancer	0.000634	0.000969	CcSEcCtD
Oxaprozin—Phenytoin—ALB—liver cancer	0.000631	0.0935	CrCbGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—SERPINE1—liver cancer	0.000626	0.00185	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—ALB—liver cancer	0.000625	0.00185	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.00062	0.00183	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000615	0.00182	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—HPGDS—liver cancer	0.000608	0.0018	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—CDKN2A—liver cancer	0.000607	0.00179	CbGpPWpGaD
Oxaprozin—Nausea—Doxorubicin—liver cancer	0.000602	0.000919	CcSEcCtD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—liver cancer	0.00058	0.00171	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000562	0.00166	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.000555	0.00164	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000547	0.00162	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—CDKN1B—liver cancer	0.000537	0.00159	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000528	0.00156	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000523	0.00155	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—CCND1—liver cancer	0.000513	0.00151	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000508	0.0015	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—UGDH—liver cancer	0.000507	0.0015	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—CDKN1A—liver cancer	0.000496	0.00147	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP2E1—liver cancer	0.000496	0.00146	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	0.000489	0.00144	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—EPT1—liver cancer	0.000476	0.00141	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000476	0.00141	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—TNF—liver cancer	0.000465	0.00137	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GGT1—liver cancer	0.000455	0.00134	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—TAT—liver cancer	0.000452	0.00133	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000444	0.00131	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000418	0.00123	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—MYC—liver cancer	0.000411	0.00122	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.00041	0.00121	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CDKN1B—liver cancer	0.000409	0.00121	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GSTP1—liver cancer	0.000409	0.00121	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000403	0.00119	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	0.000403	0.00119	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—UGDH—liver cancer	0.000402	0.00119	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CASP3—liver cancer	0.000401	0.00119	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL2—liver cancer	0.000401	0.00118	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CCND1—liver cancer	0.000391	0.00115	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000387	0.00114	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—KRAS—liver cancer	0.00038	0.00112	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MMP9—liver cancer	0.000379	0.00112	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—EPT1—liver cancer	0.000378	0.00112	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GSTM1—liver cancer	0.000376	0.00111	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IL6—liver cancer	0.000375	0.00111	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	0.000371	0.00109	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—TNF—liver cancer	0.000369	0.00109	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000362	0.00107	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TAT—liver cancer	0.000358	0.00106	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP1A1—liver cancer	0.000356	0.00105	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000353	0.00104	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	0.000351	0.00104	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000349	0.00103	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000332	0.000982	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—HRAS—liver cancer	0.000323	0.000954	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MYC—liver cancer	0.000313	0.000926	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TGFB1—liver cancer	0.000313	0.000924	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GLUL—liver cancer	0.000307	0.000907	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CPT1B—liver cancer	0.000307	0.000907	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000304	0.000898	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IL6—liver cancer	0.000298	0.00088	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NR1H4—liver cancer	0.000296	0.000875	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TNF—liver cancer	0.000292	0.000862	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTA3—liver cancer	0.000291	0.00086	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—LTF—liver cancer	0.000291	0.00086	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000279	0.000823	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000273	0.000807	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000267	0.000789	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—UGDH—liver cancer	0.000266	0.000787	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTA4—liver cancer	0.000266	0.000787	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000266	0.000785	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000265	0.000784	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000264	0.00078	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000263	0.000778	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.00026	0.000769	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTA2—liver cancer	0.000259	0.000766	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TP53—liver cancer	0.000257	0.00076	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000257	0.00076	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000251	0.000741	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—EPT1—liver cancer	0.00025	0.00074	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTA1—liver cancer	0.00025	0.000739	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NAT2—liver cancer	0.000247	0.000731	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CPT1B—liver cancer	0.000244	0.00072	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GLUL—liver cancer	0.000244	0.00072	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000238	0.000703	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TAT—liver cancer	0.000237	0.000702	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALDOB—liver cancer	0.000237	0.000701	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL6—liver cancer	0.000236	0.000696	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NR1H4—liver cancer	0.000235	0.000694	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000234	0.00069	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000232	0.000685	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTA3—liver cancer	0.000231	0.000683	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CRABP1—liver cancer	0.000226	0.000669	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ALDOB—liver cancer	0.000225	0.000665	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000213	0.00063	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000213	0.000628	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTA4—liver cancer	0.000211	0.000624	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000207	0.00061	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTA2—liver cancer	0.000206	0.000608	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000204	0.000602	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTA1—liver cancer	0.000199	0.000587	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000199	0.000587	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—HPGDS—liver cancer	0.000198	0.000585	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000197	0.000582	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000197	0.000581	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NAT2—liver cancer	0.000196	0.00058	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000189	0.000558	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALDOB—liver cancer	0.000188	0.000557	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000181	0.000535	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CRABP1—liver cancer	0.00018	0.000531	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000179	0.000529	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ADAM17—liver cancer	0.000178	0.000525	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000177	0.000523	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PSMA4—liver cancer	0.000176	0.000521	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PSMD10—liver cancer	0.000176	0.000521	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000175	0.000517	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000175	0.000516	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GOT2—liver cancer	0.000172	0.000507	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PSMD10—liver cancer	0.000167	0.000494	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PSMA4—liver cancer	0.000167	0.000494	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—GOT2—liver cancer	0.000163	0.00048	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000162	0.000478	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GLUL—liver cancer	0.000161	0.000477	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CPT1B—liver cancer	0.000161	0.000477	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP2E1—liver cancer	0.000161	0.000477	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HPGDS—liver cancer	0.000157	0.000464	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000156	0.000461	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000156	0.000461	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NR1H4—liver cancer	0.000156	0.00046	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA3—liver cancer	0.000153	0.000452	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYCS—liver cancer	0.000151	0.000446	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GOT1—liver cancer	0.000148	0.000437	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GGT1—liver cancer	0.000148	0.000437	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000148	0.000437	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000142	0.00042	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.00014	0.000415	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—GOT1—liver cancer	0.00014	0.000415	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PSMA4—liver cancer	0.00014	0.000414	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PSMD10—liver cancer	0.00014	0.000414	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA4—liver cancer	0.00014	0.000413	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000137	0.000404	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA2—liver cancer	0.000136	0.000403	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GOT2—liver cancer	0.000136	0.000402	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTP1—liver cancer	0.000133	0.000393	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA1—liver cancer	0.000132	0.000389	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—HMOX1—liver cancer	0.000131	0.000388	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NAT2—liver cancer	0.00013	0.000384	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PRKCE—liver cancer	0.000129	0.000383	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP2E1—liver cancer	0.000128	0.000378	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000125	0.00037	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALDOB—liver cancer	0.000125	0.000369	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000124	0.000366	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTM1—liver cancer	0.000122	0.000361	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYCS—liver cancer	0.00012	0.000354	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CRABP1—liver cancer	0.000119	0.000352	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GOT1—liver cancer	0.000118	0.000347	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GGT1—liver cancer	0.000118	0.000347	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP1A1—liver cancer	0.000116	0.000342	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—H2AFX—liver cancer	0.000113	0.000334	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MTHFR—liver cancer	0.000108	0.000319	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000107	0.000317	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PPARA—liver cancer	0.000106	0.000313	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTP1—liver cancer	0.000106	0.000312	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HMOX1—liver cancer	0.000104	0.000308	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HPGDS—liver cancer	0.000104	0.000307	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000103	0.000306	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTHFR—liver cancer	0.000102	0.000303	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TERT—liver cancer	0.000102	0.000302	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTM1—liver cancer	9.7e-05	0.000287	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.52e-05	0.000281	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9.42e-05	0.000278	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.3e-05	0.000275	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PSMA4—liver cancer	9.27e-05	0.000274	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PSMD10—liver cancer	9.27e-05	0.000274	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP1A1—liver cancer	9.2e-05	0.000272	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CG—liver cancer	9.07e-05	0.000268	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GOT2—liver cancer	9.02e-05	0.000266	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PPARG—liver cancer	8.76e-05	0.000259	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APC—liver cancer	8.6e-05	0.000254	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MTHFR—liver cancer	8.57e-05	0.000253	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP2E1—liver cancer	8.48e-05	0.000251	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PPARA—liver cancer	8.41e-05	0.000249	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.21e-05	0.000243	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—BRAF—liver cancer	8.09e-05	0.000239	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CD—liver cancer	7.98e-05	0.000236	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYCS—liver cancer	7.93e-05	0.000234	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALB—liver cancer	7.87e-05	0.000233	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GGT1—liver cancer	7.78e-05	0.00023	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GOT1—liver cancer	7.78e-05	0.00023	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CD—liver cancer	7.56e-05	0.000223	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.56e-05	0.000223	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SERPINE1—liver cancer	7.48e-05	0.000221	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CG—liver cancer	7.2e-05	0.000213	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTP1—liver cancer	6.99e-05	0.000207	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CB—liver cancer	6.95e-05	0.000205	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PPARG—liver cancer	6.95e-05	0.000205	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HMOX1—liver cancer	6.89e-05	0.000204	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RAF1—liver cancer	6.75e-05	0.000199	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CB—liver cancer	6.59e-05	0.000195	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTOR—liver cancer	6.59e-05	0.000195	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTM1—liver cancer	6.42e-05	0.00019	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CD—liver cancer	6.33e-05	0.000187	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALB—liver cancer	6.25e-05	0.000185	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN1B—liver cancer	6.19e-05	0.000183	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP1A1—liver cancer	6.09e-05	0.00018	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CTNNB1—liver cancer	5.84e-05	0.000173	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN1A—liver cancer	5.71e-05	0.000169	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTHFR—liver cancer	5.68e-05	0.000168	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PPARA—liver cancer	5.57e-05	0.000165	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CB—liver cancer	5.52e-05	0.000163	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—STAT3—liver cancer	5.09e-05	0.000151	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5e-05	0.000148	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CG—liver cancer	4.77e-05	0.000141	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MYC—liver cancer	4.73e-05	0.00014	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TGFB1—liver cancer	4.72e-05	0.00014	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PPARG—liver cancer	4.6e-05	0.000136	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KRAS—liver cancer	4.37e-05	0.000129	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CA—liver cancer	4.24e-05	0.000125	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CD—liver cancer	4.19e-05	0.000124	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALB—liver cancer	4.14e-05	0.000122	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CA—liver cancer	4.02e-05	0.000119	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HRAS—liver cancer	3.72e-05	0.00011	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CB—liver cancer	3.66e-05	0.000108	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6—liver cancer	3.56e-05	0.000105	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AKT1—liver cancer	3.46e-05	0.000102	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CA—liver cancer	3.36e-05	9.94e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKT1—liver cancer	3.28e-05	9.7e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AKT1—liver cancer	2.75e-05	8.12e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CA—liver cancer	2.23e-05	6.58e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AKT1—liver cancer	1.82e-05	5.38e-05	CbGpPWpGaD
